Hepatocellular carcinoma (HCC) is the most common primary liver cancer with high
morbidity and mortality worldwide. Chemotherapy is recommended to patients with …

The effectiveness of chemotherapy in hepatocellular carcinoma (HCC) is restricted by
chemo-resistance and systemic side effects. To improve the efficacy and safety of …

Hepatocellular carcinoma (HCC) is the primary liver cancer that has shown a high incidence
and mortality rate worldwide among several types of cancers. A large variety of …

Hepatocellular carcinoma (HCC) has a fairly high morbidity and is notoriously difficult to treat
due to long latent period before detection, multidrug resistance and severe drug-related …

Hepatocellular carcinoma, the most frequent solid tumor of the liver, has a very poor
prognosis, being the second most common cause of death from cancer worldwide. The …

Hepatocellular carcinoma (HCC) is one of the deadliest cancers due to its complexities,
reoccurrence after surgical resection, metastasis and heterogeneity. In addition to sorafenib …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer‐associated deaths
worldwide. There is a lack of efficient therapy for HCC; the only available first‐line systemic …

Liver cancer is one of serious diseases which threaten human life and health. Studies on the
treatment of liver cancer have attracted widespread attention. Application of nano-drug …

Efficient hepatocellular carcinoma (HCC) therapy remains a significant challenge due to the
unsatisfactory targeting efficiency of nanoparticles (NPs) with either a passive targeting or a …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide,
with high rates of recurrence and death. Surgical resection and ablation therapy have limited …